Combining core decompression with autologous stem cells creates a promising intervention for osteonecrosis of the femoral head.
Category: Innovations & Excellence 2021-22 (Page 2)
UVA presented live cases at the premier TVT Conference, including a new technique for patients who can’t be helped by standard treatment.
Researchers at UVA Health developed a new heart function measurement that could significantly reduce deaths and hospitalizations from systolic heart failure and pulmonary hypertension.
An international leader in predictive monitoring, UVA Children’s has developed technologies that improve outcomes for newborns and children.
UVA Health researchers are using artificial intelligence to advance risk evaluation and treatment options for children with disruptive gastrointestinal disease.
UVA Children’s reduced ED visits and hospital length-of-stay with the first consumer-friendly, EMR-integrated home monitoring platform.
Imre Noth, MD, helped secure $22 million in NIH and private funding to dramatically alter how idiopathic pulmonary fibrosis (IPF) is diagnosed and treated.
UVA pulmonologists established one of the nation's first post-COVID clinics and brings valuable insights into COVID’s longterm toll by tying clinical data to blood biomarkers.
Combining robust expertise with the latest robotics improves outcomes and reduces knee replacement revisions.
UVA urologist Ryan Smith, MD, developed a clinical trial to determine optimal treatment protocol and patients most likely to benefit from low-intensity shockwave therapy for erectile dysfunction.